Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-12-01T01:33:56.239Z Has data issue: false hasContentIssue false
  • English
  • Français

Longitudinal Analysis of Endemic Gentamicin- and Tobramycin-Resistant Gram-Negative Bacilli in a Community Hospital

Published online by Cambridge University Press:  02 January 2015

C. Richard Magnussen  and
Maria T. Jacobson
C. Richard Magnussen*
Affiliation:
Department of Medicine, University of Rochester School of Medicine and Dentistry and St. Mary's Hospital, Rochester, New York
Maria T. Jacobson
Affiliation:
Department of Medicine, University of Rochester School of Medicine and Dentistry and St. Mary's Hospital, Rochester, New York
*
St. Mary's Hospital, 89 Genesee Street, Rochester, NY 14611
Get access Rights & Permissions [Opens in a new window]

Abstract

The epidemiology of endemic gentamicin- and tobramycin-resistant gram-negative bacilli at a community hospital was analyzed over a one-year period three years following an original analysis at the same hospital. The frequency and distribution of resistant organisms remained stable over the time spanning the two studies. Only 2.8% of all gram-negative bacilli were resistant to gentamicin or tobramycin, and the majority of resistant isolates were non-Enterobacteriaceae. The respiratory and urinary tracts remained the body sites most prone to harbor resistant organisms. Risk analysis using a matched comparison group again revealed prior treatment with an aminoglycoside to be the only significant factor pre-disposing to acquisition of resistant gram-negative bacilli. This analysis indicates that community hospitals may not be important reservoirs of endemic aminoglycoside-resistant gram-negative bacilli, and reconfirms the observation that each hospital must define its own pattern of aminoglycoside resistance and unique risk factors.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 5 , Issue 2 , February 1984 , pp. 88 - 92
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Jauregui, L, Cushing, RD, Lerner, AM, Gentamicin amikacin resistant gram-negative bacilli at Detroit General Hospital, 1975-1976. Am J Med 1977;62:882–888.CrossRefGoogle ScholarPubMed
2.Moellering, RC Jr, Wennersten, C, Kunz, LJ, et al: Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Am J Med 1977;62:873–881.CrossRefGoogle ScholarPubMed
3.Siebert, WT, Moreland, NJ, Williams, TW, Resistance to gentamicin: A growing concern. South Med J 1977;70:289–292.CrossRefGoogle ScholarPubMed
4.Kauffman, CA, Ramundo, NC, Williams, SG, et al: Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital. Antimicrob Agents Chemother 1978;13:918–923.CrossRefGoogle ScholarPubMed
5.Lynch, JM, Hodges, GR, Clark, GM, et al: Gram-negative bacteremias. Analysis of factors for clinical assessment of gentamicin resistance. Arch Intern Med 1981;141:582–586.CrossRefGoogle ScholarPubMed
6.Magnussen, CR, Sammartino, M, Gentamicin and tobramycin resistant gram-negative bacilli in a community hospital. Infect Control 1980;1:249–252.CrossRefGoogle Scholar
7.Hospital Statistics 1977. Chicago, American Hospital Association, 1978.Google Scholar
8.Scheckler, WE, Septicemia in a community hospital 1970 through 1973. JAMA 1977;237:1938–1941.CrossRefGoogle Scholar
9.Weinstein, RA, Nathan, C, Gruensfelder, R, et al: Endemie aminoglycoside resistance in gram-negative bacilli: Epidemiology and mechanisms. J Infect Dis 1980;141:338–345.CrossRefGoogle Scholar
10.Bauer, DW, Kirby, WMM, Sherris, JC, et al: Antibiotic susceptibility testing by a standard single disc method. Am J Clin Pathol 1966;45:493–496.CrossRefGoogle Scholar
11.Smith, PB, Tomfohrde, JM, Rhoden, DL, et al: API systems: A multiple method of identification of Enterobacteriaceae. Applied Microbiology 1972;22:267–269.Google Scholar
12.Approved Standard: ASM-2. Performance Standards for Antimicrobial Disc Susceptibility Tests. Villanova, Pennsylvania, National Committee for Clinical Laboratory Standards, 1979.Google Scholar
13.Keys, TF, Washington, JA, Gentamicin-resistant Pseudomonas aeruginosa Mayo Clinic experience, 1970-1976. Mayo Clin Proc 1977;52:797–801.Google Scholar
14.Ruben, FL, Norden, CW, Hruska, E, Factors associated with acquisition of Pseudomonas aeruginosa resistant to gentamicin. Am J Med Sci 1978;275:173–179.CrossRefGoogle ScholarPubMed
15.Baltch, AL, Hammer, M, Smith, RP, et al: Pseudomonas aeruginosa bacteremia. Susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance. J Lab Clin Med 1979;94:201–214.Google ScholarPubMed
16.Yu, VL, Oakes, CA, Axnick, KJ, et al: Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med 1979;66:468–472.CrossRefGoogle Scholar